Patrick R. van Den Berg

Patrick R. van Den Berg

Auto-generated profile, based on publicly available information

Patrick R. van Den Berg

Leiden University

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2019 in PLOS Biology
Verified
Journal Article
Open access
PDF file
MHMazène Hochane
Mazène Hochane
PBPatrick R van Den Berg
Patrick R van Den Berg
XFXueying Fan
Xueying Fan
NBNoémie Bérenger-Currias
Noémie Bérenger-Currias
EAEsmée Adegeest
Esmée Adegeest
SSStefan Semrau
Stefan Semrau
The current understanding of mammalian kidney development is largely based on mouse models. Recent landmark studies revealed pervasive differences in renal embryogenesis between mouse and human. The scarcity of detailed gene expression data in humans therefore hampers a thorough understanding of human kidney development and the possible developmental origin of kidney diseases. In this paper, we present a single-cell transcriptomics study of the human fetal kidney. We identified 22 cell types and a host of marker genes. Comparison of samples from different developmental ages revealed continuous gene expression changes in podocytes. To demonstrate the usefulness of our data set, we explored the heterogeneity of the nephrogenic niche, localized podocyte precursors, and confirmed disease-associated marker genes. With close to 18,000 renal cells from five different developmental ages, this study provides a rich resource for the elucidation of human kidney development, easily accessible through an interactive web application. Regenerative medicine offers an exciting avenue to potential cures of kidney disease. However, a detailed knowledge of the structure and embryonic development of the kidney is crucial, both for stimulating regeneration in the body and for growing healthy kidney tissue in a dish. Most of such knowledge has been obtained from mice, whose development differs in crucial ways from that of humans. We therefore studied the composition of human fetal kidney tissue from five developmental ages, using a technique that can measure gene expression in individual cells. Our measurements revealed 22 distinguishable cell types, some of which we localized in the tissue by fluorescence microscopy. We found several subpopulations of nephron progenitors—cells that give rise to the nephron, the functional unit of the kidney. Our study also focused on the development of podocytes, a cell type that is crucial for the filtration function of the kidney, and our results might inform attempts to recreate these cells in a dish. We hope that our data set, made conveniently accessible through a web application, will help scientists develop new regenerative medicine approaches to kidney disease.

1 September 2019 in Molecular Cell
Verified
Journal Article
Closed access
YSYuelin Song
Yuelin Song
PBPatrick R. van Den Berg
Patrick R. van Den Berg
SMStyliani Markoulaki
Styliani Markoulaki
FSFrank Soldner
Frank Soldner
ADAlessandra Dall’aGnese
Alessandra Dall’aGnese
RJRudolf Jaenisch
Rudolf Jaenisch

17 August 2018 in Oncogene
Verified
Journal Article
Open access
PDF file
MLMark Long
Mark Long
PSPrashant K. Singh
Prashant K. Singh
JRJames R. Russell
James R. Russell
GLGerard Llimos
Gerard Llimos
SRSpencer Rosario
Spencer Rosario
MCMoray Campbell
Moray Campbell
Expression levels of retinoic acid receptor gamma (NR1B3/RARG, encodes RARγ) are commonly reduced in prostate cancer (PCa). Therefore, we sought to establish the cellular and gene regulatory consequences of reduced RARγ expression, and determine RARγ regulatory mechanisms. RARG shRNA approaches in non-malignant (RWPE-1 and HPr1-AR) and malignant (LNCaP) prostate models revealed that reducing RARγ levels, rather than adding exogenous retinoid ligand, had the greatest impact on prostate cell viability and gene expression. ChIP-Seq defined the RARγ cistrome, which was significantly enriched at active enhancers associated with AR binding sites. Reflecting a significant genomic role for RARγ to regulate androgen signaling, RARγ knockdown in HPr1-AR cells significantly regulated the magnitude of the AR transcriptome. RARγ downregulation was explained by increased miR-96 in PCa cell and mouse models, and TCGA PCa cohorts. Biochemical approaches confirmed that miR-96 directly regulated RARγ expression and function. Capture of the miR-96 targetome by biotin-miR-96 identified that RARγ and a number of RARγ interacting co-factors including TACC1 were all targeted by miR-96, and expression of these genes were prominently altered, positively and negatively, in the TCGA-PRAD cohort. Differential gene expression analyses between tumors in the TCGA-PRAD cohort with lower quartile expression levels of RARG and TACC1 and upper quartile miR-96, compared to the reverse, identified a gene network including several RARγ target genes (e.g., SOX15) that significantly associated with worse disease-free survival (hazard ratio 2.23, 95% CI 1.58 to 2.88, p = 0.015). In summary, miR-96 targets a RARγ network to govern AR signaling, PCa progression and disease outcome.

6 February 2017 in BMC Genomics
Verified
Journal Article
Open access
PDF file
PSPrashant Singh
Prashant Singh
PBPatrick R. van Den Berg
Patrick R. van Den Berg
MLMark Long
Mark Long
AVAngie Vreugdenhil
Angie Vreugdenhil
LGLaurie Grieshober
Laurie Grieshober
LSLara E. Sucheston-Campbell
Lara E. Sucheston-Campbell
The nuclear hormone receptor superfamily acts as a genomic sensor of diverse signals. Their actions are often intertwined with other transcription factors. Nuclear hormone receptors are targets for many therapeutic drugs, and include the vitamin D receptor (VDR). VDR signaling is pleotropic, being implicated in calcaemic function, antibacterial actions, growth control, immunomodulation and anti-cancer actions. Specifically, we hypothesized that the biologically significant relationships between the VDR transcriptome and phenotype-associated biology could be discovered by integrating the known VDR transcription factor binding sites and all published trait- and disease-associated SNPs. By integrating VDR genome-wide binding data (ChIP-seq) with the National Human Genome Research Institute (NHGRI) GWAS catalog of SNPs we would see where and which target gene interactions and pathways are impacted by inherited genetic variation in VDR binding sites, indicating which of VDR’s multiple functions are most biologically significant. To examine how genetic variation impacts VDR function we overlapped 23,409 VDR genomic binding peaks from six VDR ChIP-seq datasets with 191,482 SNPs, derived from GWAS-significant SNPs (Lead SNPs) and their correlated variants (r 2 > 0.8) from HapMap3 and the 1000 genomes project. In total, 574 SNPs (71 Lead and 503 SNPs in linkage disequilibrium with Lead SNPs) were present at VDR binding loci and associated with 211 phenotypes. For each phenotype a hypergeometric test was used to determine if SNPs were enriched at VDR binding sites. Bonferroni correction for multiple testing across the 211 phenotypes yielded 42 SNPs that were either disease- or phenotype-associated with seven predominately immune related including self-reported allergy; esophageal cancer was the only cancer phenotype. Motif analyses revealed that only two of these 42 SNPs reside within a canonical VDR binding site (DR3 motif), and that 1/3 of the 42 SNPs significantly impacted binding and gene regulation by other transcription factors, including NF-κB. This suggests a plausible link for the potential cross-talk between VDR and NF-κB. These analyses showed that VDR peaks are enriched for SNPs associated with immune phenotypes suggesting that VDR immunomodulatory functions are amongst its most important actions. The enrichment of genetic variation in non-DR3 motifs suggests a significant role for the VDR to bind in multimeric complexes containing other transcription factors that are the primary DNA binding component. Our work provides a framework for the combination of ChIP-seq and GWAS findings to provide insight into the underlying phenotype-associated biology of a given transcription factor.

10 January 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TMTobias C. Messemaker
Tobias C. Messemaker
SLSelina M. van Leeuwen
Selina M. van Leeuwen
PBPatrick R. van Den Berg
Patrick R. van Den Berg
AJAnke E. J. ‘t Jong
Anke E. J. ‘t Jong
RPRobert-Jan Palstra
Robert-Jan Palstra
HMHarald M. M. Mikkers
Harald M. M. Mikkers
The transcription factor Sox2 controls the fate of pluripotent stem cells and neural stem cells. This gatekeeper function requires well-regulated Sox2 levels. We postulated that Sox2 regulation is partially controlled by the Sox2 overlapping long non-coding RNA (lncRNA) gene Sox2ot. Here we show that the RNA levels of Sox2ot and Sox2 are inversely correlated during neural differentiation of mouse embryonic stem cells (ESCs). Through allele-specific enhanced transcription of Sox2ot in mouse Sox2eGFP knockin ESCs we demonstrate that increased Sox2ot transcriptional activity reduces Sox2 RNA levels in an allele-specific manner. Enhanced Sox2ot transcription, yielding lower Sox2 RNA levels, correlates with a decreased chromatin interaction of the upstream regulatory sequence of Sox2 and the ESC-specific Sox2 super enhancer. Our study indicates that, in addition to previously reported in trans mechanisms, Sox2ot can regulate Sox2 by an allele-specific mechanism, in particular during development.

27 June 2015 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MLMark Long
Mark Long
PBPatrick R. van Den Berg
Patrick R. van Den Berg
JRJames L. Russell
James L. Russell
PSPrashant K. Singh
Prashant K. Singh
SBSebastiano Battaglia
Sebastiano Battaglia
MCMoray Campbell
Moray Campbell
To define the functions of NCOR1 we developed an integrative analysis that combined ENCODE and NCI-60 data, followed by in vitro validation. NCOR1 and H3K9me3 ChIP-Seq, FAIRE-seq and DNA CpG methylation interactions were related to gene expression using bootstrapping approaches. Most NCOR1 combinations (24/44) were associated with significantly elevated level expression of protein coding genes and only very few combinations related to gene repression. DAVID's biological process annotation revealed that elevated gene expression was uniquely associated with acetylation and ETS binding. A matrix of gene and drug interactions built on NCI-60 data identified that Imatinib significantly targeted the NCOR1 governed transcriptome. Stable knockdown of NCOR1 in K562 cells slowed growth and significantly repressed genes associated with NCOR1 cistrome, again, with the GO terms acetylation and ETS binding, and significantly dampened sensitivity to Imatinib-induced erythroid differentiation. Mining public microarray data revealed that NCOR1-targeted genes were significantly enriched in Imatinib response gene signatures in cell lines and chronic myelogenous leukemia (CML) patients. These approaches integrated cistrome, transcriptome and drug sensitivity relationships to reveal that NCOR1 function is surprisingly most associated with elevated gene expression, and that these targets, both in CML cell lines and patients, associate with sensitivity to Imatinib.